News of the index components SPI

Index

SXGE

CH0009987501

Market Closed - Swiss Exchange 16:06:00 2026-10-08 EDT			5-day change	1st Jan Change
19,338.33 ^PTS	-1.11%		+0.04%	+6.14%

10-08	Swiss Market Index Retreats; Novartis Shares Decline	MT
10-07	Swiss Stocks Close in Green; UBS Group Shares Down	MT

News of the index components

10-08	Logitech International Unveils New Enterprise Video Collaboration Lineup	MT
10-08	Swiss Market Index Retreats; Novartis Shares Decline	MT
10-08	US FDA flags four deaths in Newron's schizophrenia drug studies	RE
10-08	Richemont hit as Jefferies cuts target price
10-08	AlphaValue/Baader Europe Upgrades Swissquote Group to Buy Rating	MT
10-08	Deutsche Bank Raises VAT Group PT, Affirms Hold Rating	MT
10-08	Goldman Sachs Upgrades Sonova to Buy, Boosts PT	MT
10-08	Deutsche Bank Research Lifts Inficon's PT, Affirms Buy Rating	MT
10-08	US FDA cites 4 deaths in Newron's schizophrenia drug trial hold	RE
10-08	BofA Sees Potential FY26 EPS Outlook Upgrade for Roche on Margin Expansion, 'Better' Tax Rate	MT
10-08	AlphaValue/Baader Europe Sees Midterm Upside Potential for Sika on Cost Savings, EV Battery Opportunity	MT
10-08	Swiss inflationary pressure rising but no need to change course, says SNB vice chairman	RE
10-08	Swiss inflation has risen but remains low internationally, SNB Vice Chairman says	RE
10-08	Novartis wins FDA approval for a form of chronic hives
10-08	DKSH Singapore, Novartis Forge Ophthalmology Partnership	MT
10-08	DKSH's Singaporean Arm Enters Agency Services Partnership with Novartis	MT
10-08	Addex Therapeutics' Neurosterix to Advance Schizophrenia Drug to Phase 2 Trials	MT
10-08	Newron Pharmaceuticals Reviews US FDA Feedback on Clinical Hold for Schizophrenia Drug Trial	MT
10-08	Mobimo Kicks Off Residential Project in Switzerland	MT
10-08	Addex Spin-Out Neurosterix Completes Phase 1 Clinical Studies of NTX-253 for Schizophrenia	DJ
10-08	Swiss stocks - Factors to watch on October 8	RE
10-07	Novartis' Rhapsido Gets US FDA Approval for Symptomatic Dermographism	MT
10-07	Zealand, Roche's obesity drug helps patients lose up to 9.2% weight in mid-stage trial	RE
10-07	Sika: China still weighs, but medium-term growth levers strengthen
10-07	US FDA expands use of Novartis drug for chronic skin condition	RE
10-07	Novartis Receives FDA Approval for Rhapsido to Treat Symptomatic Dermographism	MT
10-07	Swiss Stocks Close in Green; UBS Group Shares Down	MT
10-07	Fitch Upgrades Beazley's Ratings on Takeover by Zurich Insurance Group	MT
10-07	Novartis Rhapsido(R) (remibrutinib) receives FDA approval as first treatment for symptomatic dermographism (SD), expanding its use beyond chronic spontaneous urticaria (CSU)	DJ
10-07	Deutsche Bank Research Boosts Ams-Osram's PT, Keeps at Hold	MT
10-07	Deutsche Bank Research Lifts UBS Group PT, Affirms Buy Rating	MT
10-07	Berenberg Research Raises VAT Group PT, Maintains Hold Rating	MT
10-07	Barclays Initiates Coverage on Alcon AG With Equal Weight Rating, $70 Price Target	MT
10-07	Novartis to Present Key Data on Multiple Sclerosis
10-07	Novartis advances multiple sclerosis innovation with late-breaking remibrutinib and broad portfolio data at MSToronto2026	DJ
10-07	Nestlé, NBA Sign Multi-Year Marketing Deal	MT
10-07	Nestle shoots to score younger generation with NBA deal	RE
10-07	Berenberg Lifts VAT Group Estimates, Price Target on 'Stronger, Longer' Semiconductor Upcycle; Hold Maintained	MT
10-07	UBS' De Bock on Le Pen Proposal, European Energy Costs	MT
10-07	Montana Aerospace Confirms FY26, FY27 Net Sales Outlook	MT

1 2 3 4 5

No results match your criteria

Headlines

Nearly 30% growth expected on Wall Street in Q3, but beware of a disappointment…

October 05, 2026 at 10:05 am

Magnificent 1 + 6: when Meta alone carries Big Tech

October 01, 2026 at 09:45 am

LVMH, Kering, Hermès… When the luxury empire starts to wobble

September 25, 2026 at 03:02 am

Rankings

Highest SPI increases
MINDMAZE THERAPEUTICS HOLDING SA	+7.87%
ADDEX THERAPEUTICS LTD	+4.39%
ZUGER KANTONALBANK	+3.14%
STARRAGTORNOS GROUP AG	+2.83%
SMG SWISS MARKETPLACE GROUP HOLDING AG	+2.58%